Total Funding
38
24
Total FundingSeed raised
Growth Score 38 in past quarter
-2 pts
Heat Score 24 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
247982
NeVap is a medical device company that specializes in developing infection control devices.
- Brenton Hanlon: Chair and CEO
- Benjamin Wang: Founder and Chief Medical Officer
About the Company
NeVap addresses critical unmet clinical needs with innovative medical devices, dedicated to lowering critical care costs and saving precious lives. Its mission is to reduce Ventilator-Associated Pneumonia, a common, serious, deadly, and expensive hospital-acquired infection problem in modern medicine.
The company has developed the NeVap Aspire
Subglottic Suction Endotracheal Tube, an FDA & CE Mark cleared device that allows for infection protection in the operating room, intensive care unit, and emergency department.
Women Founded
